AGTR1 and cardiac hypertrophy: As the predominant peptide of RAS, angiotensin II (Ang II) exerts cardiovascular effects mainly mediated by angiotensin II type 1 receptor (AT1R), which is closely related to myocardial hypertrophy and pathological remodeling [8,9].